This is the authors' abstract. We don't add key points for this paper.
The present results showed that pamapimod was not as effective as MTX in the treatment of active RA.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Cohen et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: